Critical Outcome Technologies, Inc.

Ordinary Shares International Reporting
Verified Company Profile 11/29/2016
Contact Info
  • 700 Collip Circle
  • Suite 213
  • London, ONT N6G4X8
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jan 31, 2017 Interim Financial Report
CIK 0001585808
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Canada
Year of Inc. 2008
Employees 9 a/o Feb 03, 2017
Company Officers/Contacts
Alison Silva CEO
Gene Kelly CFO
Company Directors
John Drake Chairman
Douglas Alexander
Dr. Bharatt Chowrira
Bruno Maruzzo
David Sanderson
Alison Silva
John Yoo
Service Providers
Accounting/Auditing Firm
140 Fullarton Street
Suite 1400
London, ONT, N6A 5P2
Securities Counsel
McMillan LLP
181 Bay Street
Suite 4400
Toronto, ONT, M5J 2T3
Investor Relations Firm

Not Available
COTQF Security Details
Share Structure
Market Value1 $56,202,898 a/o Mar 23, 2017
Authorized Shares Unlimited a/o Nov 22, 2016
Outstanding Shares 149,158,435 a/o Dec 19, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 129,918,035 a/o Dec 19, 2016
Par Value No Par Value
Shareholders of Record 2,185 a/o Oct 31, 2016
Non US Stock Exchange Listing
COT - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 4,480 (88.24%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security